A feedback regulation between Kindlin-2 and GLI1 in prostate cancer cells

Jianchao Gao1, Ammad Aslam Khan, Takashi Shimokawa

  • 1Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Health Science Center, #38 Xue Yuan Road, Beijing 100191, China.

FEBS Letters
|January 23, 2013
PubMed

Insights

Kindlin-2 regulates prostate cancer progression by forming a feedback loop with GLI1, a key component of the Hedgehog signaling pathway. Targeting this loop may offer new therapeutic strategies for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Kindlin-2 plays a role in tumor progression.
  • The precise regulation of Kindlin-2 in cancer cells is not well understood.

Purpose of the Study:

  • To elucidate the regulatory mechanism of Kindlin-2 in tumor cells.
  • To investigate the relationship between Kindlin-2 and the Hedgehog signaling pathway effector, GLI1.

Main Methods:

  • Investigated the transcriptional regulation of Kindlin-2 by GLI1.
  • Examined the effect of Kindlin-2 on GLI1 expression.
  • Utilized GSK3β inactivation and Smoothened antagonist (cyclopamine) in prostate cancer cell models.

Main Results:

  • Kindlin-2 is transcriptionally downregulated by GLI1 binding to its promoter.
  • Kindlin-2 enhances GLI1 expression via GSK3β inactivation, independent of Smoothened.
  • Knockdown of Kindlin-2 combined with cyclopamine significantly reduced prostate cancer cell viability.

Conclusions:

  • A novel feedback loop exists between Kindlin-2 and GLI1 in prostate cancer.
  • This Kindlin-2-GLI1 feedback loop represents a potential therapeutic target for prostate cancer treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...